Large-scale testing (Phase 3)Study completedNCT04136366
What this trial is testing
The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy
Who this might be right for
Proliferative Vitreoretinopathy
Aldeyra Therapeutics, Inc. 106